HAN-GINS Indxx Healthcare Innovation UCITS ETF
"The revolutions occurring in biotechnology and AI...are redefining what it means to be human by pushing back the current thresholds of life span, health, cognition, and capabilities" - Klaus Schwab, Founder and Executive Chairman of the World Economic Forum
HAN-GINS Indxx Healthcare Innovation ETF (WELL) is a UCITS compliant Exchange Traded Fund domiciled in Ireland.
WELL tracks the Indxx Advanced Life Sciences & Smart Healthcare Thematic Index (Net Total Return), an index designed to measure the performance of large, mid and small-capitalisation companies primarily listed on an exchange in Developed and Emerging Markets that are involved in the Advanced Life Sciences & Smart Healthcare sector.
Please remember that the value of your investment may go down as well as up and past performance is no indication of future performance.
View Related Articles
Participate in two of the most influential structural shifts taking place in our society - Digitalisation and Aging Populations
Going far beyond traditional Big Pharma, WELL captures securities at the cross-roads of Medicine and Technology which are shaping the future of Healthcare
The strategy is sub-divided into eight distinctive themes identified through a rigorous research process, which include companies at the forefront of Healthcare innovation
As innovation is not determined by geographical boundaries or the size of a company, the fund includes companies from both developed and emerging markets across all market cap ranges
+44(0) 203 794 1800
HANetf Ltd, City Tower, 40 Basinghall St,
London, EC2V 5DE
The price of any Shares or the value of an investment in ETPs may go up or down and an investor may not get back the amount invested. Past performance is not a reliable indicator of future performance. This material is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any financial instrument or product or to adopt any investment strategy. Any decision to invest should be based on the information contained in the appropriate prospectus and after seeking independent investment, tax and legal advice.
These products may not be available in your market or suitable for you. The content of this document does not constitute investment advice nor an offer for sale nor a solicitation of an offer to buy any product or make any investment.
Select Your Country
Please choose one of the following options: